Skip to main content

Myalgic encephalomyelitis research and treatment

EDM (Early Day Motion) 31: tabled on 09 November 2023

Tabled in the 2023-24 session.

This motion has been signed by 22 Members. It has not yet had any amendments submitted.

Motion text

This House commends current research being conducted by the Quadram Institute on the Norwich Research Park that builds on recent evidence that conditions like myalgic encephalomyelitis (ME), and Long Covid, have a basis in the immune system; notes that ME (sometimes known as ME/CFS) is a severely debilitating condition thought to affect up to 250,000 people in the UK and that symptoms include widespread pain, extreme tiredness and an inability to concentrate and that the causes of ME are not known and there are no effective treatments; commends the funding provided by the charity Invest in ME Research to the Quadram Institute to run the only current clinical trial in the UK for ME; believes it is necessary to establish a Centre for ME Research, building on excellent biomedical research, to act as a hub for research and treatment of ME; and calls on the Government to support and promote such a specialist Centre to help develop effective treatments.

The first 6 Members who have signed to support the motion are the sponsors. The primary sponsor is generally the person who tabled the motion and has responsibility for it. The date shown is when the Member signed the motion.

In addition to the sponsors, the following Members have signed to support the motion.

There are no withdrawn signatures for this motion.